vs
Dominari Holdings Inc.（DOMH）与LIFECORE BIOMEDICAL, INC. \DE\（LFCR）财务数据对比。点击上方公司名可切换其他公司
LIFECORE BIOMEDICAL, INC. \DE\的季度营收约是Dominari Holdings Inc.的1.0倍（$31.1M vs $30.1M），LIFECORE BIOMEDICAL, INC. \DE\净利率更高（-32.1% vs -438.1%，领先406.0%），Dominari Holdings Inc.同比增速更快（220.4% vs -4.5%），过去两年Dominari Holdings Inc.的营收复合增速更高（369.1% vs -0.1%）
LIFECORE BIOMEDICAL, INC.是一家生物医药企业，专注于研发和生产以透明质酸为主的高品质生物材料，业务覆盖医疗应用产品、制药解决方案、个人护理原料三大核心板块，主要市场遍布北美、欧洲、亚太地区，服务头部医疗器械、制药、美妆品牌客户。
DOMH vs LFCR — 直观对比
营收规模更大
LFCR
是对方的1.0倍
$30.1M
营收增速更快
DOMH
高出224.9%
-4.5%
净利率更高
LFCR
高出406.0%
-438.1%
两年增速更快
DOMH
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $30.1M | $31.1M |
| 净利润 | $-131.8M | $-10.0M |
| 毛利率 | — | 25.0% |
| 营业利润率 | -8.9% | -9.9% |
| 净利率 | -438.1% | -32.1% |
| 营收同比 | 220.4% | -4.5% |
| 净利润同比 | -12426.2% | -52.0% |
| 每股收益（稀释后） | $-6.94 | $-0.29 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMHLFCR
| Q4 25 | $30.1M | — | ||
| Q3 25 | $50.8M | $31.1M | ||
| Q2 25 | $34.1M | — | ||
| Q1 25 | $8.1M | $35.2M | ||
| Q4 24 | $9.4M | $32.6M | ||
| Q3 24 | $4.0M | $24.7M | ||
| Q2 24 | $6.2M | — | ||
| Q1 24 | $1.4M | $35.7M |
净利润DOMHLFCR
| Q4 25 | $-131.8M | — | ||
| Q3 25 | $125.2M | $-10.0M | ||
| Q2 25 | $16.6M | — | ||
| Q1 25 | $-32.5M | $-14.8M | ||
| Q4 24 | $1.1M | $-6.6M | ||
| Q3 24 | $-4.2M | $-16.2M | ||
| Q2 24 | $-6.1M | — | ||
| Q1 24 | $-5.4M | $15.6M |
毛利率DOMHLFCR
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
营业利润率DOMHLFCR
| Q4 25 | -8.9% | — | ||
| Q3 25 | -3.1% | -9.9% | ||
| Q2 25 | -57.0% | — | ||
| Q1 25 | -394.6% | -25.7% | ||
| Q4 24 | 0.4% | -6.0% | ||
| Q3 24 | -79.1% | -46.9% | ||
| Q2 24 | -44.3% | — | ||
| Q1 24 | -205.2% | -2.5% |
净利率DOMHLFCR
| Q4 25 | -438.1% | — | ||
| Q3 25 | 246.4% | -32.1% | ||
| Q2 25 | 48.7% | — | ||
| Q1 25 | -400.5% | -42.0% | ||
| Q4 24 | 11.4% | -20.2% | ||
| Q3 24 | -104.2% | -65.7% | ||
| Q2 24 | -99.1% | — | ||
| Q1 24 | -398.0% | 43.8% |
每股收益（稀释后）DOMHLFCR
| Q4 25 | $-6.94 | — | ||
| Q3 25 | $7.27 | $-0.29 | ||
| Q2 25 | $1.12 | — | ||
| Q1 25 | $-3.02 | $-0.47 | ||
| Q4 24 | $0.21 | $-0.25 | ||
| Q3 24 | $-0.67 | $-0.53 | ||
| Q2 24 | $-1.01 | — | ||
| Q1 24 | $-0.91 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.5M | $18.9M |
| 总债务越低越好 | — | $136.0M |
| 股东权益账面价值 | $69.4M | $-10.5M |
| 总资产 | $112.9M | $235.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOMHLFCR
| Q4 25 | $80.5M | — | ||
| Q3 25 | $176.2M | $18.9M | ||
| Q2 25 | $28.2M | — | ||
| Q1 25 | $18.9M | $5.4M | ||
| Q4 24 | $8.2M | $9.5M | ||
| Q3 24 | $7.2M | — | ||
| Q2 24 | $12.1M | — | ||
| Q1 24 | $7.1M | — |
总债务DOMHLFCR
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
股东权益DOMHLFCR
| Q4 25 | $69.4M | — | ||
| Q3 25 | $210.2M | $-10.5M | ||
| Q2 25 | $88.6M | — | ||
| Q1 25 | $42.4M | $2.2M | ||
| Q4 24 | $39.9M | $15.4M | ||
| Q3 24 | $38.3M | $-3.9M | ||
| Q2 24 | $42.4M | — | ||
| Q1 24 | $47.7M | $17.7M |
总资产DOMHLFCR
| Q4 25 | $112.9M | — | ||
| Q3 25 | $223.4M | $235.2M | ||
| Q2 25 | $109.3M | — | ||
| Q1 25 | $52.3M | $237.7M | ||
| Q4 24 | $47.1M | $255.4M | ||
| Q3 24 | $43.4M | $246.8M | ||
| Q2 24 | $49.1M | — | ||
| Q1 24 | $52.2M | $246.2M |
负债/权益比DOMHLFCR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.7M | $1.8M |
| 自由现金流经营现金流 - 资本支出 | — | $25.0K |
| 自由现金流率自由现金流/营收 | — | 0.1% |
| 资本支出强度资本支出/营收 | — | 5.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-16.8M |
8季度趋势，按日历期对齐
经营现金流DOMHLFCR
| Q4 25 | $22.7M | — | ||
| Q3 25 | $-4.9M | $1.8M | ||
| Q2 25 | $-353.0K | — | ||
| Q1 25 | $1.2M | $1.2M | ||
| Q4 24 | $-16.7M | $-6.1M | ||
| Q3 24 | $-4.7M | $-613.0K | ||
| Q2 24 | $1.4M | — | ||
| Q1 24 | $-8.6M | $-1.4M |
自由现金流DOMHLFCR
| Q4 25 | — | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | — | $-4.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.8M |
自由现金流率DOMHLFCR
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | — | -16.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -21.8% |
资本支出强度DOMHLFCR
| Q4 25 | — | — | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 13.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 17.8% |
现金转化率DOMHLFCR
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
